Study of neuropsychiatric symptom management identifies sub-optimal use of treatments

Rates of pharmacological treatment of neuropsychiatric symptoms are low in patients with early Parkinson’s disease (PD), according to new findings presented at MDS 2020.

Researchers at the University of Pennsylvania, in Philadelphia, USA, performed a longitudinal cohort study of 395 early untreated PD outpatients (mean age 62 years), and 185 healthy matched controls, enrolled in the Parkinson’s Progression Markers Initiative.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.